Former VP at CMC Biologics AS
- Recent trends and developments in biologic contract manufacturing and key players' competitive positioning across geographies
- M&A and organic growth strategies and outsourcing trends
- Growth expectations across microbial fermentation, mammalian cell cultures and CGT (cell and gene therapy)
- Q4 2021 industry outlook and growth dynamics for large and small players
Gain access to Premium Content
Submit your details to access up to 5 Forum Transcripts or to request a complimentary one week trial.